Among the various public portfolio startups of the fund, we may underline Cybrexa Therapeutics Moreover, a startup needs to be at the age of 2-3 years to get the investment from the fund. We can highlight the next thriving fund investment areas, such as Biotechnology, Therapeutics.
The typical case for the fund is to invest in rounds with 3 participants. Despite the Cycle Venture Partners, startups are often financed by HighCape Partners, Connecticut Innovations. The meaningful sponsors for the fund in investment in the same round are HighCape Partners, Connecticut Innovations.
The fund is constantly included in less than 2 deals per year. Deals in the range of 10 - 50 millions dollars are the general things for fund. The important activity for fund was in 2019.
Besides them, we counted 1 critical employee of this fund in our database.
|8i Ventures||India, Maharashtra, Mumbai|
|Chinese Media||China, Guangdong, Jiangxi|
|Guanda Ruitou||Beijing, Beijing, China|
|Huizenga Capital Management||Illinois, Oak Brook, United States|
|Langfang Wuxian||Beijing, China, Tongzhou|
|MDC Ventures||New York, New York, United States|
|Milla Investment AS||Norway, Oslo|
|New Life Ventures||-|
|NewGaoQiao E-Business||China, Fujian, Hunan|
|Novastar Ventures||Kenya, Nairobi, Nairobi Area|
|Owl Ventures||California, San Francisco, United States|
|Rabo Frontier Ventures||Netherlands, Utrecht, Utrecht|
|RS Investments||California, San Francisco, United States|
|Salem Partners||California, Los Angeles, United States|
|Salt Lake Life Science Angels||Salt Lake City, United States, Utah|
|The Libra Foundation||California, San Francisco, United States|
|Zhiyou Fangcun||China, Guangdong, Shenzhen|
|$4M||08 Apr 2021||Rocky Hill, Connecticut, United States|
|$13M||21 Jun 2019||New Haven, Connecticut, United States|
– Lumeda, a medical technology company, announced the closing of its $4.3M Series A financing.
– The round was led by Connecticut Innovations, with participation from Cycle Venture Partners and brings the total amount raised to date to $5.3m.
– Both firms, along with angel investors, participated in the company’s Seed funding round in early 2020.
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.